Vinflunine: all 22 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsActive, not recruitingNCT03390504Phase 3Results posted
• Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerCompletedNCT02347332Phase 3Results posted
• A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedNCT02054338Phase 3Results posted
• Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT01953003Phase 3Results posted
• Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedNCT01095003Phase 3Results posted
• Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedNCT01091168Phase 3Results posted
• Vinflunine in Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00545766Phase 2Results posted
• Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCTerminatedNCT00519831Phase 2Results posted
• Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung CancerCompletedNCT00284154Phase 2Results posted
• Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)WithdrawnNCT02845050Phase 1/2
• A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionCompletedNCT02665039Phase 2
• A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)CompletedNCT02057913Phase 2
• Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractCompletedNCT01844947Phase 1
• JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinCompletedNCT01599013Phase 2
• Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial CancerCompletedNCT01529411Phase 2
• A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced CancerWithdrawnNCT00534807Phase 1
• Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnNCT00450515Phase 2
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based TherapyCompletedNCT00389155Phase 2/3
• A Study of the Alternative Administration of Ixabepilone and VinflunineCompletedNCT00362830Phase 1
• A Study of Vinflunine in Patients With Gastric CancerTerminatedNCT00359476Phase 2/3
• A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00251446Phase 2
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00101608Phase 2

← Vinflunine overview